Pars plana vitrectomy in diabetic macular edema.

Department of Ophthalmology, University of Bari, Italy.
Documenta Ophthalmologica (Impact Factor: 1.11). 01/1999; 97(3-4):471-4. DOI: 10.1023/A:1002464307469
Source: PubMed

ABSTRACT To ascertain the association between the improvement of diabetic macular edema and increased visual acuity after pars plana vitrectomy.
From January 1994 to December 1996 we prospectively studied 18 patients (18 eyes, 7 women and 11 men, mean age 52 years, range 37-68) with type II diabetes and clinically significant macular edema. One group was composed of 9 patients presenting diffuse macular edema (DME); a second group with 9 patients presented cystoid macular edema (CME). All patients underwent pars plana vitrectomy.
Preoperative Snellen visual acuity was 20/143 in DME and 20/441 in CME. In both groups vision increased to 20/136 and 20/205, respectively, postoperatively. For the DME this difference was statistically significant (p<0.05) at 1 month after the surgery, but vision decreased again after 10 months reaching preoperative values.
Our results suggest that pars plana vitrectomy for diabetic macular edema may increase visual acuity in diffuse macular edema, although this increase is only short lived.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Based on the theory of Timoshenko and thin-walled beams, a new finite element model of spatial thin-walled beams with general open cross sections is presented in the paper, in which several factors are included such as lateral shear deformation, warp generated by nonuniform torsion and second-order shear stress, coupling of flexure and torsion, and large displacement with small strain. With an additional internal node in the element, the element stiffness matrix is deduced by incremental virtual work in updated Lagrangian (UL) formulation. Numerical examples demonstrate that the presented model well describes the geometrically nonlinear property of spatial thin-walled beams.
    Acta Mechanica Solida Sinica - ACTA MECH SOLIDA SINICA. 01/2009; 22(1):64-72.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Das Makuladem wurde bereits Ende des 19. Jahrhunderts als Krankheitsbild beschrieben. Urschlich kommen berwiegend vaskulre, entzndliche, degenerative und kongenitale Erkrankungen oder Traumata in Frage. Mit zunehmender Kenntnis ber die Pathogenese des Makuladems haben sich auch die Therapieanstze im Laufe der Zeit gewandelt. Sie umfassen neben der Laserbehandlung oder der medikamentsen Therapie auch die chirurgische Intervention. Die Pars-plana-Vitrektomie (evtl. mit ILM-Peeling) scheint vor allem bei bestimmten Formen des Makuladems, die mit Pathologien des Glaskrpers bzw. der vitreoretinalen Grenzflche einhergehen, erfolgversprechend. Zur Behandlung therapieresistenter Formen des Makuladems gewinnt auch die intravitreale Medikamentenapplikation, z.B. von Triamcinolon, an Bedeutung.At the end of the nineteenth century, macular edema had already been recognized as a pathological condition. The main causes for macular edema are vascular, inflammatory, degenerative, and congenital diseases or trauma. The therapeutic approaches have changed along with the increasing knowledge on the underlying causes of action during the last few years and include laser treatment as well as surgical interventions. Pars plana vitrectomy (including ILM peeling) seems beneficial in cases of macular edema that are associated with alterations of the vitreous or the vitreoretinal interface. For the treatment of chronic macular edema, intravitreal application of agents such as triamcinolone has become an option.
    Der Ophthalmologe 05/2004; 101(6):618-625. · 0.72 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: An abstract is unavailable. This article is available as HTML full text and PDF.
    Evidence-Based Ophthalmology 12/2005; 7(1):38-39.